Roth Capital Starts Recro Pharma (REPH) at Buy

September 16, 2016 8:45 AM EDT
Get Alerts REPH Hot Sheet
Price: $6.99 -2.92%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 31 | New: 25
Trade REPH Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Roth Capital initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $24.00.

For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.

Shares of Recro Pharma closed at $9.31 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment